HenryMRosevearMD

Urology • Troy, MI

Physician

Join to view full profile

Dr. Rosevear is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rosevear's full profile

Already have an account?

Office
130 Town Center Dr
Ste 101
Troy, MI 48084
Phone+1 248-740-0670

Fax+1 248-740-0668

Education & Training

University of Iowa Hospitals and ClinicsResidency, Urology, 2007 - 2013
University of Michigan Medical SchoolClass of 2007

Certifications & Licensure

MI State Medical License 2023 - 2026
CO State Medical License 2012 - 2025
IA State Medical License 2007 - 2013
American Board of Urology Urology

Publications & Presentations

PubMed

75 citations
Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non–muscle invasive bladder cancer
Andrew J. Lightfoot, Benjamin N. Breyer, Henry M. Rosevear, Bradley A. Erickson, Badrinath R. Konety
Urologic Oncology. 2014-01-01
21 citations
Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intr...
Henry M. Rosevear, Andrew J. Lightfoot, Kenneth G. Nepple, Michael A. O’Donnell
The Journal of Urology. 2011-01-01
62 citations
Utility of the RENAL nephrometry scoring system in the real world: predicting surgeon operative preference and complication risk.
Henry M. Rosevear, Paul Gellhaus, Andrew J. Lightfoot, Timothy P. Kresowik, Fadi N. Joudi
BJU International. 2012-03-01

Press Mentions

‘Countdown to Zero’: Endocrine Disruptors and Worldwide Sperm CountsAugust 26th, 2021
Debating the Value of PSA Prostate ScreeningFebruary 24th, 2020
Online Medical Billing and Coding CourseJune 15th, 2018
Join now to see all